2024年会见AZN管理：肺癌和QCS报告

AstraZeneca Z Meet AZN Management: Lung Cancer and QCS Investor event 09 September 2024 | Virtual Webcast This event is not for participants of the 2024 IASLC World Congress on Lung Cancer Forward-looking statements 2 In order, among other things, to utilise the 'safe harbour' provisions of the US Private Securities Litigation Reform Act of 1995, AstraZeneca (hereafter 'the Group') provides the following cautionary statement: This document contains certain forward-looking statements with respect to the oper ...